Description of Business - Additional Information (Details) - USD ($) $ in Thousands |
9 Months Ended | ||
|---|---|---|---|
Mar. 25, 2025 |
Dec. 31, 2025 |
Mar. 31, 2025 |
|
| Description Of Business And Summary Of Significant Accounting Policies [Line Items] | |||
| Escrow receivable | $ 0 | $ 1,000 | |
| Period of escrow | 15 months | ||
| Minimum [Member] | |||
| Description Of Business And Summary Of Significant Accounting Policies [Line Items] | |||
| Percentage of Drug Candidate | 10.00% | ||
| Metacrine, Inc. [Member] | |||
| Description Of Business And Summary Of Significant Accounting Policies [Line Items] | |||
| Upfront payment paid | $ 10,000 | ||
| Closing upfront payment | 9,000 | ||
| Escrow receivable | 1,000 | ||
| Metacrine, Inc. [Member] | Metacrine's FXR Program [Member] | |||
| Description Of Business And Summary Of Significant Accounting Policies [Line Items] | |||
| Upfront payment paid | 10,000 | ||
| Closing upfront payment | 9,000 | ||
| Escrow receivable | $ 1,000 | ||
| Future milestone | $ 50,000 |